Elevated mRNA for transformative medicines
Location: United States
Total raised: $13M
Investors 3
| Date | Name | Website |
| - | SBXi | sbxi.com |
| - | North Sout... | northsouth... |
| - | SurgePoint... | surgepoint... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.05.2026 | Seed | $13M | Breyer Cap... |
Mentions in press and media 3
| Date | Title | Description |
| 07.05.2026 | ParcelBio Raises $13M in Seed Funding | ParcelBio, a San Francisco, CA-based biotechnology company developing a new class of potent and durable mRNA medicines, raised $13M in Seed funding. The round was led by Breyer Capital, with participation from General Catalyst, Y Combinator... |
| 07.05.2026 | ParcelBio: $13 Million Seed Financing Raised To Advance Next-Generation mRNA Medicines | ParcelBio launched with $13 million in seed financing led by Breyer Capital, with participation from General Catalyst, Y Combinator, Metaplanet, SurgePoint Capital, ZAKA VC, and additional investors. The company said the financing will supp... |
| - | ParcelBio | “ParcelBio” |